11 17 Abscess 190 77.9 19.5 2.6 12 6 Sepsis: empiric therapy 563 80.8 17.1 2.1 13 15 Diverticulitis 219 85.8 14.2 0.0 14 14 Osteomyelitis 249 81.9 13.3 4.8 15 18 Sepsis: gram-negative bacteraemia 188 87.2 12.8 0.0 16 19 Diabetic infection (including foot) 169 88.2 11.2 0.6 17 12 Sepsis: gram-positive bacteraemia 261 89.7 10.0 0.4 18 13 Febrile neutropenia 258 92.6 6.6 0.8 19 3 Medical prophylaxis (bacterial, 1320 89.9 6.4 3.6 viral and fungal) 20 11 Oral candidiasis 332 89.8 5.7 4.5 COPD = chronic obstructive pulmonary disease a Rank in the 20 most common indications, where 1 is the most common indication Source: NAPS, 2014
11 17 Abscess 190 77.9 19.5 2.6 12 6 Sepsis: empiric therapy 563 80.8 17.1 2.1 13 15 Diverticulitis 219 85.8 14.2 0.0 14 14 Osteomyelitis 249 81.9 13.3 4.8 15 18 Sepsis: gram-negative bacteraemia 188 87.2 12.8 0.0 16 19 Diabetic infection (including foot) 169 88.2 11.2 0.6 17 12 Sepsis: gram-positive bacteraemia 261 89.7 10.0 0.4 18 13 Febrile neutropenia 258 92.6 6.6 0.8 19 3 Medical prophylaxis (bacterial, viral and fungal) 1320 89.9 6.4 3.6 20 11 Oral candidiasis 332 89.8 5.7 4.5 COPD = chronic obstructive pulmonary disease a Rank in the 20 most common indications, where 1 is the most common indication Source: NAPS, 2014
AURA-2016-Supplementary-Data.docx